F/m美国国库3年期票据 ETF UTRE 深 沪
等待开盘 05-18 09:30:00 美东时间
49.115
-0.120
-0.24%
华盛通- 最 高49.15
- 今 开49.15
- 成交量 871股
- 最 低 49.1101
- 昨 收 49.235
- 总市值 982.30万
- 52周最高 49.6689
- 市盈率 静 --
- 换手率 0.44%
- 52周最低 47.6849
- 委 比 0.00%
- 总股本 20.00万
- 历史最高 49.6689
- 量 比 0.07
- 振 幅 0.08%
- 历史最低 43.3495
- 每 手 1
- 风险率 0.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Liquidia Reports Strong Q1 Profitability Driven by YUTREPIA
An announcement from Liquidia Technologies ( ($LQDA) ) is now available. Liquid...
05-11 19:21
Liquidia Q1 EPS beats estimates as YUTREPIA sales drive profit
Liquidia Q1 EPS beats estimates as YUTREPIA sales drive profit Overview US biopharma firm's Q1 revenue rose on YUTREPIA sales, third straight profitable quarter EPS for Q1 beat analyst expectations Company saw increased patient uptake and more prescribers for YUTREPIA since launch Outlook Company di
05-11 18:38
Liquidia Analysts Boost Their Forecasts After Q4 Earnings
Liquidia Corp (LQDA) reported mixed Q4 results, with earnings missing estimates but sales beating expectations. Analysts have mixed opinions on stock.
03-07 00:17
Demystifying Liquidia: Insights From 7 Analyst Reviews
Across the recent three months, 7 analysts have shared their insights on Liquid...
03-06 21:00
Liquidia's 2025 EPS misses analyst expectations
Liquidia's 2025 EPS misses analyst expectations Overview Biopharmaceutical firm's YUTREPIA sales led to second consecutive profitable qtr Company ended 2025 with $190.7 mln cash, up $33.2 mln from Q3 EPS for 2025 missed analyst expectations Outlook Liquidia plans to deepen prescriber adoption and gr
03-05 19:38
Liquidia Q4 net income hits USD 14.6 million as FY SG&A rises 93% to USD 157.2 million
Liquidia Q4 net income hits USD 14.6 million as FY SG&A rises 93% to USD 157.2 million Liquidia said FY 2025 net product sales were USD 148.3 million, including USD 90.1 million in Q4 2025, driven by YUTREPIA following its June 2025 U.S. launch. FY 2025 service revenue, net was USD 10.0 million (dow
03-05 19:31
Liquidia FY 2025 Earnings Preview
Liquidia (LQDA) is scheduled to announce FY earnings results on Thursday, March 5th, before market open. The consensus EPS Estimate is -$0.62 (+62.7% Y/Y) and the consensus Revenue Estimate is $153.82...
03-04 23:37
Liquidia Unveils New Clinical Data on Inhaled Treprostinil Therapies at PVRI 2026 Congress
Liquidia Unveils New Clinical Data on Inhaled Treprostinil Therapies at PVRI 2026 Congress Liquidia Corporation announced that it will present new clinical data across its portfolio at the Pulmonary Vascular Research Institute (PVRI) 2026 Annual Congress, taking place January 28 through February 1,
01-28 01:27
BRIEF-Alcon Releases Investor Discussion Materials of Merger Proposal for STAAR Stockholders
Nov 4 (Reuters) - ALCON AG ALCC.S: ALCON RELEASES INVESTOR DISCUSSION MATERIALS REINFORCING CERTAIN VALUE OF MERGER PROPOSAL FOR STAAR STOCKHOLDERS PLANS TO INITIATE OUTREACH TO STAAR STOCKHOLDERS AND...
2025-11-04 14:07
Liquidia Corporation reports $51.7 million in YUTREPIA net product sales for Q3 2025
Liquidia Corporation reported net product sales of YUTREPIA totaling $51.7 million for the third quarter of 2025, marking its first full quarter of profitability since launch. Net loss for the period ...
2025-11-03 19:30
